Browsing byAuthorAustralian Pancreatic Cancer Genome Initiative (APGI)
Showing results 1 to 1 of 1
| Issue Date | Title | Author(s) |
| 2020-02 | MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma. | Castillo, L; Young, AIJ; Mawson, A; Schafranek, P; Steinmann, AM; Nessem, D; Parkin, A; Johns, A; Chou, A; Law, AMK; Lucas, MC; Murphy, KJ; Deng, N; Gallego-Ortega, D; Caldon, CE; Australian Pancreatic Cancer Genome Initiative (APGI); Timpson, P; Pajic, M; Ormandy, CJ; Oakes, SR |
